114 related articles for article (PubMed ID: 15736291)
1. Telmisartan vs. enalapril in type 2 diabetes.
Loewenstein JE
N Engl J Med; 2005 Feb; 352(8):835-6; author reply 835-6. PubMed ID: 15736291
[No Abstract] [Full Text] [Related]
2. Telmisartan vs. enalapril in type 2 diabetes.
Asgari AA; Sarvghadi F; Zahed N
N Engl J Med; 2005 Feb; 352(8):835-6; author reply 835-6. PubMed ID: 15728820
[No Abstract] [Full Text] [Related]
3. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
[TBL] [Abstract][Full Text] [Related]
4. [Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
Zidek W
MMW Fortschr Med; 2004 Oct; 146(42):51-2. PubMed ID: 15536706
[No Abstract] [Full Text] [Related]
5. [Detail study of angiotensin-receptor blockade versus ACE-inhibition in type 2 diabetes with nephropathy].
Nitschmann S; Girndt M; Köhler H
Internist (Berl); 2005 Aug; 46(8):923-4, 926. PubMed ID: 15990988
[No Abstract] [Full Text] [Related]
6. Telmisartan vs. enalapril in type 2 diabetes.
Parving HH; Hovind P; Rossing P
N Engl J Med; 2005 Feb; 352(8):835-6; author reply 835-6. PubMed ID: 15736292
[No Abstract] [Full Text] [Related]
7. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
Barnett AH
Acta Diabetol; 2005 Apr; 42 Suppl 1():S42-9. PubMed ID: 15868119
[TBL] [Abstract][Full Text] [Related]
8. [In the DETAIL. Kidney protection in manifestations of microalbuminuria].
MMW Fortschr Med; 2006 Jun; 148(26):51. PubMed ID: 16875382
[No Abstract] [Full Text] [Related]
9. Rationale and design of diabetics exposed to telmisartan and enalapril (DETAIL) study.
Rippin J; Bain SC; Barnett AH;
J Diabetes Complications; 2002; 16(3):195-200. PubMed ID: 12015188
[TBL] [Abstract][Full Text] [Related]
10. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
Nakamura T; Fujiwara N; Kawagoe Y; Sugaya T; Ueda Y; Koide H
Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
[TBL] [Abstract][Full Text] [Related]
11. Reduction of proteinuria with angiotensin receptor blockers.
Galle J
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S36-43. PubMed ID: 18580865
[TBL] [Abstract][Full Text] [Related]
12. Prevention of loss of renal function over time in patients with diabetic nephropathy.
Barnett A
Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
[TBL] [Abstract][Full Text] [Related]
13. A hypertensive snow bird.
Lexchin J
CMAJ; 2005 Nov; 173(11):1357; discussion 1358. PubMed ID: 16301706
[No Abstract] [Full Text] [Related]
14. A hypertensive snow bird.
Marlow B
CMAJ; 2005 Nov; 173(11):1357-8; discussion 1358. PubMed ID: 16301705
[No Abstract] [Full Text] [Related]
15. Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure.
Nakamura T; Sugaya T; Koide H
Diabetologia; 2007 Feb; 50(2):490-2. PubMed ID: 17171364
[No Abstract] [Full Text] [Related]
16. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.
Neutel JM; Smith DH; Reilly PA
Int J Clin Pract; 1999; 53(3):175-8. PubMed ID: 10665127
[TBL] [Abstract][Full Text] [Related]
17. Impact of telmisartan on coronary stenting in patients with acute myocardial infarction compared with enalapril.
Yokoyama J; Higuma T; Tomita H; Abe N; Oikawa K; Fujiwara T; Yokota T; Yokoyama H; Kimura M; Sasaki S; Hanada H; Osanai T; Okumura K
Int J Cardiol; 2009 Feb; 132(1):114-20. PubMed ID: 18190989
[TBL] [Abstract][Full Text] [Related]
18. Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial.
Barnett A
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S132-5. PubMed ID: 16565237
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
[TBL] [Abstract][Full Text] [Related]
20. eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists.
Kosugi T; Heinig M; Nakayama T; Matsuo S; Nakagawa T
Am J Pathol; 2010 Feb; 176(2):619-29. PubMed ID: 20042665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
